The Supreme Court has announced that it has scheduled a Conference inSequenom, Inc. v. Ariosa Diagnostics, Inc., Supreme Court No. 15-1182, to vote whether to grant certiorari in this important case.

§ 101 Patent-Eligibility:  Petitioner questions whether a method to determine the presence in a blood sample of a known substance (here, DNA) is patent-eligible under 35 USC § 101 where that substance, as such, is known and not in any event patent-eligible.

Details are included in the current Top Ten Patent Cases at pp. 5-9 (attached).

TopTenCasesJune8

Regards,

Hal